The HeraBEAT foetal heart rate monitor. Source: HeraMED
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • HeraMED (HMD) partners with e-Lōvu Health to supply its HeraCARE remote pregnancy monitoring technology to customers in the United States
  • The companies strike a binding term sheet that will see the HeraMED supply 1000 kits to expectant mothers at e-Lōvu’ partner healthcare provider sites
  • During the first year, e-Lōvu will pay HeraMED about US$550,000 (A$787,000) for the technology and a HeraCARE license
  • The first e-Lōvu site is expected to launch by the end of the year, with full deployment expected in the next six to twelve months
  • Shares in HeraMED are up 25 per cent to 16 cents per share at 10:17 am AEST

Pregnancy care tech specialist HeraMED (HMD) has partnered with e-Lōvu Health to supply its HeraCARE remote pregnancy monitoring technology to customers in the United States.

The companies have signed a binding term sheet that will see HeraMED supply 1000 kits to expectant mothers at e-Lōvu’ partner healthcare provider sites.

The kits to be provided under the deal include the HeraBEAT foetal heart rate monitor and Bluetooth-connected blood pressure cuffs with HeraCARE connectivity, which allow future mothers to monitor their pregnancies.

During the first year of the deal, e-Lōvu will pay HeraMED about US$550,000 (A$787,000) for the technology and a HeraCARE license.

However, this is subject to e-Lōvu Health securing the required funding, which is expected at the end of the third quarter this year.

The first e-Lōvu site is expected to launch by the end of the year, with full deployment expected in the next six to twelve months.

Following the initial period, the companies plan to enter a long-term strategic partnership.

HeraMED CEO and Cofounder David Groberman said he saw great potential in the partnership.

“The deal clearly validates the advantages of our technology and business model and officially launches our commercialisation into the United States market,” Mr Groberman said.

Shares in HeraMED were up 25 per cent to 16 cents per share at 10:17 am AEST.

HMD by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX Ltd drops on ASIC $150M raise request; iron ore offsets gold bounceback

Good Afternoon and welcome to Market Close for Monday of Week 51, I’m Jon Davidson.
HotCopper Daily Market Trends Graphic

Monday’s HotCopper trends: Winsome, 4D Medical, and other daily topics | Dec 15

With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front
A dirt road running through the Antimony Canyon project in Utah.

American Tungsten and Antimony leaves ‘Trigg’ name behind to start next era (and set fresh focus)

American Tungsten and Antimony has entered a new era, leaving the name "Trigg Minerals" behind to…
The Market Online Video

How to manage money on the average Aussie income

This week on Money and Investing, Mitch Olarenshaw and I break down how to manage money on the average Australian income, using practical